Characterization of Isolated Right Ventricular Congestion in Cardiogenic Shock
Abstract Body (Do not enter title and authors here): Introduction: Right ventricular (RV) congestion has been associated with poor outcomes in cardiogenic shock (CS); however, the clinical profile of pts with CS & isolated RV congestion has been less well characterized. We aimed to describe the severity of illness, resource utilization & mortality in pts with isolated RV congestion compared to other congestive profiles. Methods: The Critical Care Cardiology Trials Network is a multicenter registry of CICUs coordinated by the TIMI Study Group (Boston, MA). Pts with CS with invasive hemodynamic assessment within 24h of CICU admission (2018-2023) & not on mechanical circulatory support (MCS) at the time were included. Congestive profiles were defined by right atrial pressure (RAP) & pulmonary capillary wedge pressure (PCWP): isolated RV (RAP≥12 & PCWP<18); isolated left ventricular (LV: RAP<12 & PCWP≥18); biventricular (BiV: RAP≥12 & PCWP≥18), and non-congested (NC: RAP<12 & PCWP<18).
Results: Of 2121 pts with CS, 1186 (56%) met the inclusion criteria with 7.1% classified as RV congestion, 61.6% as BiV, 18.5% as LV & 12.7% as NC. The RV group was more likely to be female & have pulmonary disease than others & less likely to have prior HF or severe valve disease than LV & BiV. The RV congestion group had lower pulmonary artery pulsatility index & higher pulmonary vascular resistance than LV & NC (p<0.05 for all); MAP & CI were similar across groups. PE was a contributor to CS in 1.2% and pHTN in 13.1% of RV cases. The RV group more often presented with de novo HF-CS, where BiV & LV more often had acute on chronic HF-CS. The RV group tended to have worse shock severity by SOFA score, lactate, vasoactive-inotropic score (global p<0.05 for all) & SCAI stage (panel A) and was more likely to have a cardiac arrest (p=0.010). The RV group had greater use of mechanical ventilation & renal replacement, but lower use of MCS (panel B). CICU mortality was significantly higher in the RV group compared to other profiles (panel C), including after adjustment for cardiac arrest & CS etiology. Conclusion: In pts with CS, isolated RV congestion was associated with the highest presenting illness severity, resource utilization & mortality when compared to other congestive profiles.
Kaur, Gurleen
( Brigham and Women's Hospital
, Boston
, Massachusetts
, United States
)
Berg, David
( Brigham and Women's Hospital
, Boston
, Massachusetts
, United States
)
Van Diepen, Sean
( UNIVERSITY OF ALBERTA
, Edmonton
, Alberta
, Canada
)
Katz, Jason
( NYU Langone
, New York
, New York
, United States
)
Guo, Jianping
( Brigham and Women's Hospital
, Boston
, Massachusetts
, United States
)
Morrow, David
( Brigham and Women's Hospital
, Boston
, Massachusetts
, United States
)
Bohula, Erin
( Brigham and Women's Hospital
, Boston
, Massachusetts
, United States
)
Author Disclosures:
Gurleen Kaur:DO NOT have relevant financial relationships
| David Berg:DO NOT have relevant financial relationships
| Sean Van Diepen:DO NOT have relevant financial relationships
| Jason Katz:DO have relevant financial relationships
;
Researcher:Abbott Corporation:Active (exists now)
; Other (please indicate in the box next to the company name):Abiomed, DSMB Member:Active (exists now)
; Speaker:Zoll Corporation:Past (completed)
| Jianping Guo:DO have relevant financial relationships
;
Other (please indicate in the box next to the company name):I am a member of the TIMI Study Group which has received institutional research grant support through Brigham and Women’s Hospital from: : Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Ionis Pharmaceuticals, Inc., Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche, Saghmos Therapeutics, Inc., Softcell Medical Limited, The Medicines Company, Verve Therapeutics, Inc., Zora Biosciences:Active (exists now)
| David Morrow:No Answer
| Erin Bohula:No Answer